Rocket Pharmaceuticals Inc header image

Rocket Pharmaceuticals Inc

RCKT

Equity

ISIN null / Valor 39764376

NASDAQ (2026-02-24)
USD 4.25+6.52%

Rocket Pharmaceuticals Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Rocket Pharmaceuticals Inc is a biotechnology company focused on developing gene therapy treatments for rare, life-threatening disorders by directly targeting genetic mutations in affected cells. The company's multi-platform pipeline includes treatments for diseases such as Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Danon Disease, Pyruvate Kinase Deficiency, arrhythmogenic cardiomyopathy, dilated cardiomyopathy, and other undisclosed diseases. With a strategic approach to gene therapy, Rocket Pharmaceuticals Inc aims to provide innovative solutions for patients with unmet medical needs in the field of genetic disorders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-57.7%1Y
-76.6%3Y
-92.4%5Y

Performance

131%1Y
88.7%3Y
84.2%5Y

Volatility

Market cap

460 M

Market cap (USD)

Daily traded volume (Shares)

3,113,198

Daily traded volume (Shares)

1 day high/low

12.25 / 11.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
2.00
Nature:
starstarstarstarstar
2.00
Pascale Gonzalez
Switzerland, 16 Apr 2025
star star star star star
So la la

EQUITIES OF THE SAME SECTOR

Teleflex Inc
Teleflex Inc Teleflex Inc Valor: 976212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.81%USD 112.12
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%USD 71.64
Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 61.68
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.15%USD 0.39
APONTIS PHARMA AG
APONTIS PHARMA AG APONTIS PHARMA AG Valor: 111377632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 11.00
Bausch + Lomb Corporation
Bausch + Lomb Corporation Bausch + Lomb Corporation Valor: 116024614
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 18.44
PACS Group Inc
PACS Group Inc PACS Group Inc Valor: 133777092
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.79%USD 39.66
Tenet Healthcare Corp
Tenet Healthcare Corp Tenet Healthcare Corp Valor: 19722583
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.63%USD 237.58
Conmed Corp
Conmed Corp Conmed Corp Valor: 920278
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.50%USD 46.06
National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%USD 157.45